International comparison of acute myocardial infarction care and outcomes using quality indicators.
Aged
Coronary Angiography
/ trends
Female
Healthcare Disparities
/ trends
Humans
Israel
/ epidemiology
Male
Middle Aged
Myocardial Infarction
/ diagnostic imaging
Outcome and Process Assessment, Health Care
/ trends
Percutaneous Coronary Intervention
/ adverse effects
Practice Patterns, Physicians'
/ trends
Quality Indicators, Health Care
/ trends
Registries
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United Kingdom
/ epidemiology
acute myocardial infarction
quality and outcomes of care
Journal
Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
25
09
2018
revised:
15
12
2018
accepted:
17
12
2018
pubmed:
1
2
2019
medline:
26
5
2020
entrez:
1
2
2019
Statut:
ppublish
Résumé
To compare temporal changes in European Society of Cardiology (ESC) acute myocardial infarction (AMI) quality indicator (QI) attainment in the UK and Israel. Data cross-walking using information from the Myocardial Ischaemia National Audit Project and the Acute Coronary Syndrome in Israel Survey for matching 2-month periods in 2006, 2010 and 2013 was used to compare country-specific attainment of 14 ESC AMI QIs. Patients in the UK (n=17 068) compared with Israel (n=5647) were older, more likely to be women, and had less diabetes, dyslipidaemia and heart failure. Baseline ischaemic risk was lower in Israel than the UK (Global Registry of Acute Coronary Events (GRACE) risk, 110.5 vs 121.0). Overall, rates of coronary angiography (87.6% vs 64.8%) and percutaneous coronary intervention (70.3% vs 41.0%) were higher in Israel compared with the UK. Composite QI performance increased more in the UK (1.0%-86.0%) than Israel (70.2%-78.0%). Mortality rates at 30 days declined in each country, with lower rates in Israel in 2013 (4.2% vs 7.6%). Composite QI adherence adjusted for GRACE risk score was inversely associated with 30-day mortality (OR 0.95; CI 0.95 to 0.97, p<0.001). International comparisons of guideline recommended AMI care and outcomes can be quantified using the ESC AMI QIs. International implementation of the ESC AMI QIs may reveal country-specific opportunities for improved healthcare delivery.
Identifiants
pubmed: 30700519
pii: heartjnl-2018-314197
doi: 10.1136/heartjnl-2018-314197
doi:
Types de publication
Comparative Study
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
820-825Subventions
Organisme : Wellcome Trust
ID : 206470/Z/17/Z
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.